Research Links Uterine Scar Collagen to Inflammation and Invasive Placenta in Placenta Accreta

A recent study has shed light on the role of scar tissue, particularly collagen, in the development of placenta accreta—a serious pregnancy condition characterized by abnormal placental invasion into the uterine wall. Researchers from the University of Connecticut, led by associate professor Kshitiz, investigated how scar tissue influences cellular behavior within the uterus.

Placenta accreta is increasingly common, especially with the rise of Cesarean sections, which leave a scar on the uterine wall. Traditional views suggest that the placenta invades the scar area because it’s an 'empty road' for invasion. However, Kshitiz's team challenges this explanation, proposing that the collagen-rich environment of the scar actually promotes the invasive process.

Using advanced models of uterine tissue, the researchers discovered that collagen transforms the local cellular environment into one prone to inflammation. Specifically, they found that calcium infiltrates through channels in the scar tissue, triggering an inflammatory response. This inflammation leads to the release of molecules that recruit placental cells aggressively, facilitating their invasion into the uterine tissue.

The team created a synthetic scar matrix mimicking the collagen composition of uterine scars associated with placenta accreta. This model revealed how collagen channels open in the scar, fueling calcium influx and inflammation, thus promoting placental cell invasion.

This pioneering research enhances understanding of how scar tissue contributes to invasive placental conditions and opens the door for future studies targeting these mechanisms. It also highlights the importance of recognizing scar tissue’s biological effects beyond its physical presence, offering potential pathways for preventing or treating placenta accreta.

More details can be found in the original study: Du Wenqiang et al, 'Scar matrix drives Piezo1 mediated stromal inflammation leading to placenta accreta spectrum,' published in Nature Communications (2024).